Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · Real-Time Price · USD

0.3200

-0.0167 (-4.96%)

At close: Aug 17, 2026, 4:00 PM EDT

0.3210

+0.0010 (0.31%)

Pre-market: Aug 18, 2026, 7:29 AM EDT

Heron Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	61	238	233	255	297	931
Market Cap Growth	-70.20%	2.44%	-8.79%	-14.16%	-68.06%	-51.60%
Enterprise Value	166	331	340	358	333	892
Last Close Price	0.32	1.30	1.53	1.70	2.50	9.13

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	209.09	-	-	-	-
PS Ratio	0.40	1.54	1.61	2.01	2.76	10.78
PB Ratio	10.35	16.63	-6.91	-7.51	21.90	12.00
P/TBV Ratio	10.37	17.95	-	-	21.90	12.00

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.10	2.14	2.36	2.82	3.10	10.34

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	21.48	9.81	-5.28	-5.29	11.60	2.06
Net Debt / Equity Ratio	15.30	6.56	-3.52	-2.92	5.35	0.03
Net Debt / EBITDA Ratio	-12.10	-419.67	-13.11	-1.10	-0.44	-0.01
Net Debt / FCF Ratio	-8.71	-3.37	-4.89	-1.64	-0.49	-0.01
Asset Turnover	0.62	0.63	0.63	0.54	0.39	0.26
Inventory Turnover	0.70	0.74	1.16	2.07	2.59	3.89
Quick Ratio	1.44	1.42	1.51	1.76	1.66	2.72
Current Ratio	2.49	2.48	2.29	2.37	2.50	3.58
Return on Equity (ROE)	-	-	-	-	-399.43%	-140.53%
Return on Assets (ROA)	-2.80%	-0.65%	-3.16%	-24.56%	-38.01%	-41.04%
Return on Capital Employed (ROCE)	-6.80%	-1.60%	-8.10%	-65.10%	-100.40%	-92.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-56.05%	-8.47%	-5.84%	-43.34%	-61.24%	-23.71%
FCF Yield	-19.97%	-11.71%	-10.41%	-23.65%	-50.04%	-22.18%
Buyback Yield / Dilution	-20.47%	-9.35%	-10.36%	-26.87%	-10.57%	-8.48%

SEC Filings: 10-K · 10-Q